EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 02013R0160-20130802

Consolidated text: Commission Implementing Regulation (EU) No 160/2013 of 21 February 2013 amending Regulations (EC) No 162/2003, (EC) No 971/2008, (EU) No 1118/2010 and (EU) No 169/2011 and Implementing Regulation (EU) No 888/2011 as regards the name of the holder of the authorisation of diclazuril in animal feed (Text with EEA relevance)Text with EEA relevance

ELI: http://data.europa.eu/eli/reg_impl/2013/160/2013-08-02

02013R0160 — EN — 02.08.2013 — 001.001


This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document

►B

COMMISSION IMPLEMENTING REGULATION (EU) No 160/2013

of 21 February 2013

amending Regulations (EC) No 162/2003, (EC) No 971/2008, (EU) No 1118/2010 and (EU) No 169/2011 and Implementing Regulation (EU) No 888/2011 as regards the name of the holder of the authorisation of diclazuril in animal feed

(Text with EEA relevance)

(OJ L 049 22.2.2013, p. 50)

Amended by:

 

 

Official Journal

  No

page

date

►M1

COMMISSION IMPLEMENTING REGULATION (EU) No 667/2013 of 12 July 2013

  L 192

35

13.7.2013




▼B

COMMISSION IMPLEMENTING REGULATION (EU) No 160/2013

of 21 February 2013

amending Regulations (EC) No 162/2003, (EC) No 971/2008, (EU) No 1118/2010 and (EU) No 169/2011 and Implementing Regulation (EU) No 888/2011 as regards the name of the holder of the authorisation of diclazuril in animal feed

(Text with EEA relevance)



▼M1 —————

▼B

Article 2

Amendment to Regulation (EC) No 971/2008

In column 2 of the Annex to Regulation (EC) No 971/2008 the words ‘Janssen Pharmaceutica nv’ are replaced by ‘Eli Lilly and Company Ltd’.

Article 3

Amendment to Regulation (EU) No 1118/2010

In column 2 of the Annex to Regulation (EU) No 1118/2010 the words ‘Janssen Pharmaceutica NV’ are replaced by ‘Eli Lilly and Company Ltd’.

Article 4

Amendment to Regulation (EU) No 169/2011

In column 2 of the Annex to Regulation (EU) No 169/2011 the words ‘Janssen Pharmaceutica N.V.’ are replaced by ‘Eli Lilly and Company Ltd’.

Article 5

Amendment to Implementing Regulation (EU) No 888/2011

In column 2 of the Annex to Implementing Regulation (EU) No 888/2011 the words ‘Janssen Pharmaceutica N.V.’ are replaced by ‘Eli Lilly and Company Ltd’.

Article 6

Transitional measure

Existing stocks of this additive which are in conformity with the provisions applying before the date of entry into force of this Regulation may continue to be placed on the market and used until they are exhausted.

Article 7

Entry into force

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Top